ES384611A1 - Pharmaceutical preparations - Google Patents

Pharmaceutical preparations

Info

Publication number
ES384611A1
ES384611A1 ES384611A ES384611A ES384611A1 ES 384611 A1 ES384611 A1 ES 384611A1 ES 384611 A ES384611 A ES 384611A ES 384611 A ES384611 A ES 384611A ES 384611 A1 ES384611 A1 ES 384611A1
Authority
ES
Spain
Prior art keywords
active substance
excipient
converted
pharmaceutical preparations
strained
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES384611A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Farbwerke Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG, Farbwerke Hoechst AG filed Critical Hoechst AG
Publication of ES384611A1 publication Critical patent/ES384611A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

Procedure for the preparation of a structured drug form with release of active substance that can be controlled, based on a hardly soluble excipient in the digestive tract that can be strained and at least one pharmaceutically active substance which is contained dissolved, suspended or emulsified in the excipient, characterized in that from substances known per se as excipients capable of being converted into drops and from the active substance, a melt is produced, the quantitative proportions of the components of which are adjusted in such a way that it melts only from about 45ºC and this molten mass is preferably converted into droplets into a gas, and within this it is brought to solidification and the droplet-shaped beads obtained are collected without subsequent secondary configuration to give a medicated form. (Machine-translation by Google Translate, not legally binding)
ES384611A 1969-10-17 1970-10-16 Pharmaceutical preparations Expired ES384611A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19691952304 DE1952304A1 (en) 1969-10-17 1969-10-17 Process for the production of a dosage form with controlled release of active ingredients

Publications (1)

Publication Number Publication Date
ES384611A1 true ES384611A1 (en) 1973-06-01

Family

ID=5748430

Family Applications (1)

Application Number Title Priority Date Filing Date
ES384611A Expired ES384611A1 (en) 1969-10-17 1970-10-16 Pharmaceutical preparations

Country Status (10)

Country Link
AR (1) AR193341A1 (en)
AT (1) AT317433B (en)
BE (1) BE757586A (en)
CA (1) CA937866A (en)
DE (1) DE1952304A1 (en)
ES (1) ES384611A1 (en)
FR (1) FR2070141B1 (en)
GB (1) GB1325742A (en)
NL (1) NL7014922A (en)
ZA (1) ZA707072B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU520409B2 (en) * 1977-05-25 1982-01-28 Commonwealth Scientific And Industrial Research Organisation Controlled release composition
DE3124983A1 (en) * 1981-06-25 1983-01-20 Meditest Inst Fuer Medizinisch ORAL ADMINISTRATIVE FORMS
GB2118040A (en) * 1982-02-15 1983-10-26 Hoechst Uk Ltd Oral anti-diabetic preparation
DE3833446A1 (en) * 1988-10-01 1990-04-05 Hoechst Ag METHOD FOR THE PRODUCTION OF MEDICAMENT PARTICLES WITH IMPROVED FLUID, STORAGE AND FORMULATION PROPERTIES AND MEDICAMENTS CONTAINING SUCH MEDICAMENT PARTICLES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1175826B (en) * 1959-10-23 1964-08-13 Olin Mathieson Process for the manufacture of medicinal preparations for oral administration
GB1073718A (en) * 1964-06-25 1967-06-28 Smith Kline French Lab Improvements relating to the production of sustained-release pharmaceutical pellets
NL7004971A (en) * 1969-04-12 1970-10-14

Also Published As

Publication number Publication date
DE1952304A1 (en) 1971-05-06
FR2070141B1 (en) 1974-04-12
AR193341A1 (en) 1973-04-23
CA937866A (en) 1973-12-04
AT317433B (en) 1974-08-26
BE757586A (en) 1971-04-15
FR2070141A1 (en) 1971-09-10
GB1325742A (en) 1973-08-08
ZA707072B (en) 1971-09-29
NL7014922A (en) 1971-04-20

Similar Documents

Publication Publication Date Title
FR2657257B1 (en) PROCESS FOR THE PREPARATION OF DRUGS IN THE FORM OF PEARLS.
ES423856A1 (en) Delayed release pharmaceutical preparations
ES2117642T3 (en) PHARMACEUTICAL PREPARATION CONTAINING N-GLYCOFUROLES AND N-ETILEN GLYCOLS.
FR2512670B1 (en) CAPSULES CONTAINING THE ACTIVE INGREDIENT OF AN ALLERGEN AND PROCESS FOR THEIR PREPARATION
ES488168A0 (en) PROCESS FOR THE PREPARATION OF PHARMACEUTICAL OR MEDICINAL TABLETS FOR ORAL ADMINISTRATION, WITH DELAYED DELIVERY OF ACTIVE ACTIVE, IN TABLETS IN WHICH THE QUANTITY OF RELEASE OF THE ACTIVE AGENT IS DEFAULT.
ES321779A1 (en) A method for developing pharmaceutical compositions. (Machine-translation by Google Translate, not legally binding)
YU48766B (en) Procedure for production of pharmaceutical preparation for oral dosage with reduced speed of realise of active substance without solution
NL7606908A (en) BENZOFURAN CARBONIC ACID DERIVATIVES AND PHARMACEUTICAL PREPARATION AND PROCESS FOR PREPARING THEM.
KR970003052B1 (en) Suppositories
ES384611A1 (en) Pharmaceutical preparations
JPS5726615A (en) Improving method for absorbability of slightly soluble drug
ES297425A1 (en) Procedure for preparing pharmaceutical compositions in the form of deferred action tablets (Machine-translation by Google Translate, not legally binding)
DE2860724D1 (en) Pseudomonic acid c, pharmaceutically acceptable salts or esters thereof, processes for their preparation and pharmaceutical or veterinary compositions containing them
ES449062A1 (en) Pharmaceutical compositions
BE847541A (en) NEW PHENOLIC ETHERS DISBSTITUTED FROM 3-AMINO-2-HYDROXYPROPANE, THEIR PREPARATION PROCESS AND THE MEDICINAL PRODUCT CONTAINING THEM
FR1472901A (en) Process for the preparation of stable combined drugs in capsule form
Zunin Marijuana: The drug and the problem.
US4146648A (en) Chemotherapeutic composition
US3140233A (en) Tasteless pharmaceutical composition and process
CN108542909B (en) Aspirin phospholipid solidified composition, preparation method thereof and pharmaceutical preparation
Hammond et al. Proceedings: Cyclic nucleotides and ethanol withdrawal head-twitches in mice.
ES361494A1 (en) Procedure for the preparation of medicines with prolonged release of active substance. (Machine-translation by Google Translate, not legally binding)
JPH07112927A (en) Production of capsule of herb medicine
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
BE833019A (en) NEW ESTERS OF 5-N-BUTYLPYRIDINE-2-CARBOXYLIC ACID, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS